Related Experiment Video
Updated: May 4, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Managing clinically significant findings in research: the UK10K example.
Jane Kaye1, Matthew Hurles2, Heather Griffin1
1Nuffield Department of Population Health, HeLEX - Centre for Health, Law and Emerging Technologies, University of Oxford, Oxford, UK.
Researchers developed a pathway to manage clinically significant findings (CSFs) discovered during human genome sequencing. This system allows for appropriate feedback to participants without creating an obligation for researchers.
Area of Science:
- Genomics
- Bioethics
Background:
- Advances in human genome sequencing generate detailed data, including potential health insights for participants.
- Traditionally, research studies do not return clinically significant findings (CSFs) to participants, but this practice is under scrutiny.
Purpose of the Study:
- To describe a management pathway developed by the UK10K consortium for handling CSFs discovered in genomic research.
- To outline criteria for determining which findings and participants qualify for feedback.
Main Methods:
- Development of a detailed management pathway for CSFs.
- Establishment of specific criteria for CSF feedback eligibility.
Main Results:
- The UK10K consortium created a pathway to facilitate the return of CSFs to research participants.
- The pathway aims to manage potential difficulties and risks associated with feedback.
Conclusions:
- The described mechanism provides a framework for managing CSFs in genomic research.
- This pathway can be adopted by future consortia and inform ethical principles for handling such findings.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Ethics in Research
Clinical Trials: Overview
Preclinical Development: Overview
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
